Tengion Newswire

Comprehensive Real-Time News Feed for Tengion.

Results 1 - 8 of 8 in Tengion

  1. Tengion Inc. Provides Clinical Update And Reports Second Quarter 2014 Financial ResultsRead the original story

    Aug 13, 2014 | BioSpace

    Tengion, Inc. , a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended June 30, 2014.

    Comment?

  2. Tengion says regenerative kidney treatment trial on trackRead the original story w/Photo

    Aug 13, 2014 | Business Journal

    Tengion , the Winston-Salem biotech company working to commercialize some of the technologies developed by Dr. Anthony Atala and the Wake Forest Institute for Regenerative Medicine , said the Phase 1 clinical trial of its Neo-Kidney Augment is on track so far.

    Comment?

  3. Tengion Provides Clinical Update and Reports Second Quarter 2014 Financial ResultsRead the original story

    Aug 13, 2014 | GlobeNewswire

    Tengion, Inc. , a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended June 30, 2014.

    Comment?

  4. Tengion says it needs a partner for a key potential regenerative medicine technologyRead the original story

    May 15, 2014 | Business Journal

    Tengion won't keep developing one of its key regenerative medicine product candidates unless it can find a partner to share the cost, the company said in its quarterly earnings report.

    Comment?

  5. Tengion says it needs a partner for a key potential regenerative medicine technologyRead the original story

    May 15, 2014 | Business Journal

    Tengion won't keep developing one of its key regenerative medicine product candidates unless it can find a partner to share the cost, the company said in its quarterly earnings report.

    Comment?

  6. Tengion reports clinical progress as losses mountRead the original story

    Mar 27, 2014 | Business Journal

    A Tengion lab technician loads centrifuge to collect bladder cells from tissue. The company says it made good progress in the clinic in 2013, though its financial losses continue to mount.

    Comment?

  7. Tengion Inc. Reports Fourth Quarter And Full Year 2013 Financial ResultsRead the original story

    Mar 27, 2014 | BioSpace

    Tengion, Inc. , a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2013 and provided a business update.

    Comment?

  8. Tengion Reports Fourth Quarter and Full Year 2013 Financial ResultsRead the original story

    Mar 26, 2014 | GlobeNewswire

    Tengion, Inc. , a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2013 and provided a business update.

    Comment?